The effects of perinatal steroid therapy on growth factor levels during different stages of the developing brain

Area of Science:

• Neuroscience
• Developmental Biology
• Pharmacology

Background:

• Excessive glucocorticoid (GC) exposure during fetal development can adversely affect the central nervous system (CNS).
• The timing of GC exposure may be critical in determining its impact on brain maturation.
• Understanding these effects is crucial for managing pregnancies involving GC therapy.

Purpose of the Study:

• To investigate the differential effects of betamethasone (a synthetic GC) on growth factor levels during various stages of brain maturation in a rat model.
• To evaluate how the timing of GC exposure influences neuronal development and growth factor responses.

Main Methods:

• Forty-two rat pups were divided into six groups based on the timing of betamethasone administration (postnatal days 1, 2, or 3).
• Control groups received saline injections.
• Neuronal density and growth factor levels were assessed via immunohistochemistry 24 hours after the final injection.

Main Results:

• Betamethasone administration on postnatal days 1 and 2 (equivalent to 22-28 human gestational weeks) significantly decreased hippocampal neuronal count compared to controls.
• Administration on postnatal day 3 (equivalent to 28-32 human gestational weeks) did not result in a significant difference in neuronal count.
• Growth factor responses varied depending on the timing of steroid exposure and the specific brain region examined.

Conclusions:

• The impact of glucocorticoids on neuronal count and growth factor response is critically dependent on the developmental stage of the brain at the time of exposure.
• This developmental timing sensitivity may explain the variable beneficial and deleterious effects of GCs on the developing central nervous system.